Recombinant Human MIA Protein, CF Summary
Gly25-Gln131, with an N-terminal Met
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
|Formulation||Lyophilized from a 0.2 μm filtered solution in PBS and Trehalose.|
|Reconstitution||Reconstitute at 400 μg/mL in PBS.|
|Shipping||The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.|
|Stability & Storage:||Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
When Recombinant Human Fibronectin Fragment 4 (Catalog # 3624-FN) is coated at 1 μg/mL, Recombinant Human MIA (Catalog # 9250-IA) binds with a typical ED50of 1-6 μg/mL.
Melanoma Inhibiting Activity (MIA), also known as cartilage-derived retinoic acid-sensitive protein (CD-RAP), is an approximately 11-15 kDa protein that is secreted as a noncovalent homodimer and is structurally related to OTOR/Otoraplin and MIA-2 (1). Mature human MIA contains a SH3 domain and shares 90% and 92% amino acid sequence identity with mouse and rat MIA, respectively (2). Alternative splicing generates a short isoform that lacks the SH3 domain (3). MIA is widely expressed in developing and regenerating cartilage and in the endothelium and parenchyma of developing lungs (4). MIA disrupts cellular interactions with the extracellular matrix by binding to Integrins alpha 4 beta 1 and alpha 5 beta 1 (5). It competes with Fibronectin fragments for Integrin binding and interferes with Integrin signaling (5). It also functions as a chemoattractant for mesenchymal stem cells and enhances their BMP-2 and TGF-beta 3 induced differentiation into chondrocytes [tscheud]. MIA-deficient mice exhibit delayed chondrocyte differentiation but enhanced chondrocyte proliferation and cartilage repair (7). MIA is up-regulated in several cancers including malignant melanoma, lung adenoma, metastatic oral squamous cell carcinoma, neurofibromatosis type 1 (NF-1)-related tumors, and pancreatic cancer (2, 4, 8-10). It is selectively secreted and internalized from the trailing pole of migrating cells (11, 12). This polarization reduces cellular attachment to the matrix at the trailing pole and contributes to directional tumor cell migration (2, 10, 13, 14).
- Schmidt, J. et al. (2013) Histol. Histopathol. 28:421.
- Blesch, A. et al. (1994) Cancer Res. 54:5695.
- Hau, P. et al. (2002) J. Invest. Dermatol. 119:562.
- Lin, S. et al. (2008) Dev. Biol. 316:441.
- Bauer, R. et al. (2006) J. Biol. Chem. 281:11669.
- Tscheudschilsuren, G. et al. (2006) Exp. Cell Res. 312:63.
- Schmid, R. et al. (2010) Cell Death Dis. 1:e97.
- Marr, D.G. et al. (2004) Int. J. Oncol. 25:105.
- Sasahira, T. et al. (2010) Eur. J. Cancer 46:2285.
- El Fitori, J. et al. (2005) Cancer Cell Int. 5:3.
- Schmidt, J. et al. (2010) Cell Res. 20:1224.
- Schmidt, J. and A.K. Bosserhoff (2009) Int. J. Cancer 125:1587.
- Poser, I. et al. (2004) Oncogene 23:6115.
- Guba, M. et al. (2000) Brit. J. Cancer 83:1216.
No product specific FAQs exist for this product, however you mayView all Proteins and Enzyme FAQs
Reviews for Recombinant Human MIA Protein, CF
Average Rating: 5 (Based on 1 Review)
Have you used Recombinant Human MIA Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image